PARP1 and Parkinson disease: Finally, we used the in vivo 6-OHDA mouse model for PD to demonstrate that nicotine inhibits PARP-1 and caspase-3 cleavage, suggesting a potential downstream molecular mechanism for neuroprotection in PD.